India's Aurobindo shares hit nine-month low on U.S. price fixing lawsuit

MUMBAI (Reuters) - Indian drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after it was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly-used drugs in the United States.